Su Wei, Kang John, Sopher Bryce, Gillespie James, Aloi Macarena S, Odom Guy L, Hopkins Stephanie, Case Amanda, Wang David B, Chamberlain Jeffrey S, Garden Gwenn A
Department of Neurology, University of Washington, Seattle, Washington, USA.
Department of Pathology, University of Washington, Seattle, Washington, USA.
J Neurochem. 2016 Jan;136 Suppl 1(0 1):49-62. doi: 10.1111/jnc.13081. Epub 2015 Mar 20.
Microglia are a specialized population of myeloid cells that mediate CNS innate immune responses. Efforts to identify the cellular and molecular mechanisms that regulate microglia behaviors have been hampered by the lack of effective tools for manipulating gene expression. Cultured microglia are refractory to most chemical and electrical transfection methods, yielding little or no gene delivery and causing toxicity and/or inflammatory activation. Recombinant adeno-associated viral (rAAVs) vectors are non-enveloped, single-stranded DNA vectors commonly used to transduce many primary cell types and tissues. In this study, we evaluated the feasibility and efficiency of utilizing rAAV serotype 2 (rAAV2) to modulate gene expression in cultured microglia. rAAV2 yields high transduction and causes minimal toxicity or inflammatory response in both neonatal and adult microglia. To demonstrate that rAAV transduction can induce functional protein expression, we used rAAV2 expressing Cre recombinase to successfully excise a LoxP-flanked miR155 gene in cultured microglia. We further evaluated rAAV serotypes 5, 6, 8, and 9, and observed that all efficiently transduced cultured microglia to varying degrees of success and caused little or no alteration in inflammatory gene expression. These results provide strong encouragement for the application of rAAV-mediated gene expression in microglia for mechanistic and therapeutic purposes. Neonatal microglia are functionally distinct from adult microglia, although the majority of in vitro studies utilize rodent neonatal microglia cultures because of difficulties of culturing adult cells. In addition, cultured microglia are refractory to most methods for modifying gene expression. Here, we developed a novel protocol for culturing adult microglia and evaluated the feasibility and efficiency of utilizing Recombinant Adeno-Associated Virus (rAAV) to modulate gene expression in cultured microglia.
小胶质细胞是一类特殊的髓样细胞,介导中枢神经系统的固有免疫反应。由于缺乏有效的基因表达操纵工具,确定调节小胶质细胞行为的细胞和分子机制的研究工作受到了阻碍。培养的小胶质细胞对大多数化学和电转染方法具有抗性,基因传递很少或没有,还会导致毒性和/或炎症激活。重组腺相关病毒(rAAV)载体是非包膜单链DNA载体,常用于转导多种原代细胞类型和组织。在本研究中,我们评估了利用rAAV2血清型(rAAV2)调节培养的小胶质细胞中基因表达的可行性和效率。rAAV2具有高转导效率,在新生和成年小胶质细胞中引起的毒性或炎症反应最小。为了证明rAAV转导可诱导功能性蛋白表达,我们使用表达Cre重组酶的rAAV2成功切除了培养的小胶质细胞中一个两侧带有LoxP的miR155基因。我们进一步评估了rAAV血清型5、6、8和9,观察到它们都能不同程度地有效转导培养的小胶质细胞,并且对炎症基因表达几乎没有改变。这些结果为rAAV介导的基因表达在小胶质细胞中的机制研究和治疗应用提供了有力支持。新生小胶质细胞在功能上与成年小胶质细胞不同,尽管大多数体外研究使用啮齿动物新生小胶质细胞培养物,因为培养成年细胞存在困难。此外,培养的小胶质细胞对大多数基因表达修饰方法具有抗性。在这里,我们开发了一种培养成年小胶质细胞的新方法,并评估了利用重组腺相关病毒(rAAV)调节培养的小胶质细胞中基因表达的可行性和效率。